Transfusion medicine is the branch of medicine that encompasses all aspects of the transfusion of blood and blood components including aspects related to hemovigilance. It includes issues of blood donation, immunohematology and other laboratory testing for transfusion-transmitted diseases, management and monitoring of clinical transfusion practices, patient blood management, therapeutic apheresis, stem cell collections, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations related to blood products are also a large part of the field.
A financial institution, sometimes called a banking institution, is a business entity that provides service as an intermediary for different types of financial monetary transactions. Broadly speaking, there are three major types of financial institution:
- Depository institution – deposit-taking institution that accepts and manages deposits and makes loans, including bank, building society, credit union, trust company, and mortgage broker;
- Contractual institution – insurance company and pension fund
- Investment institution – investment bank, underwriter, and other different types of financial entities managing investments.
Supervised injection sites (SIS) or Drug Consumption Rooms (DCRs) are a health and social response to drug-related problems. They are fixed or mobile spaces where people who use drugs are provided with sterile drug use equipment and can use illicit drugs under the supervision of trained staff. They are usually located in areas where there is an open drug scene and where injecting in public places is common. The primary target group for DCR services are people who engage in risky drug use.
Basiliximab, sold under the brand name Simulect, is a monoclonal antibody used to prevent rejection in kidney transplants. It is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used in combination with other medicines used to prevent organ rejection.
Carisoprodol, sold under the brand name Soma among others, is a medication used for musculoskeletal pain. Use is only approved for up to three weeks. Effects generally begin within half an hour and last for up to six hours. It is taken orally.
The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA).
The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.
The Komfo Anokye Teaching Hospital also known as GEE for it heavy equipments (KATH) in Kumasi, Ashanti Region, Ghana, is the second-largest hospital in Ghana, and the only tertiary health institution in the Ashanti Region.
The Royal Norwegian Ministry of Health and Care Services is a Norwegian government ministry in charge of health policy, public health, health care services, and health legislation in Norway. It is led by the Minister of Health and Care Services.
Law enforcement in Sweden is carried out by several government agencies, under the guidance of the Government of Sweden.
Pholcodine is an opioid cough suppressant (antitussive). It helps suppress unproductive coughs and also has a mild sedative effect, but has little or no analgesic effects. It is also known as morpholinylethylmorphine and homocodeine.
Insulin glulisine is a rapid-acting modified form of medical insulin that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and approved for marketing by the FDA and the EMA in 2004; it is sold under the trade name Apidra. When injected subcutaneously, it appears in the blood earlier than regular human insulin (RHI). When used as a meal time insulin, the dose is to be administered within 15 minutes before or 20 minutes after starting a meal. Intravenous injections may also be used for extreme hyperglycemia, but must be performed under the supervision of a medical professional.
ILOG S.A. was an international software company purchased and incorporated into IBM announced in January, 2009. It created enterprise software products for supply chain, business rule management, visualization and optimization. The main product line for Business Rules Management Systems (BRMS) has been rebranded as IBM Operational Decision Management. Many of the related components retain the ILOG brand as a part of their name.
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) and patented in September 2006.
DNV is an international accredited registrar and classification society headquartered in Høvik, Norway. As of 2020, the company has about 12,000 employees and 350 offices operating in more than 100 countries and provides services for several industries, including maritime, oil and gas, renewable energy, electrification, and healthcare. DNV GL was created in 2013 as a result of a merger between two leading organizations in the field — Det Norske Veritas (Norway) and Germanischer Lloyd (Germany). In 2021, DNV GL changed its name to DNV while retaining its post-merger structure.
Commercial offshore diving, sometimes shortened to just offshore diving, generally refers to the branch of commercial diving, with divers working in support of the exploration and production sector of the oil and gas industry in places such as the Gulf of Mexico in the United States, the North Sea in the United Kingdom and Norway, and along the coast of Brazil. The work in this area of the industry includes maintenance of oil platforms and the building of underwater structures. In this context "offshore" implies that the diving work is done outside of national boundaries. Technically it also refers to any diving done in the international offshore waters outside of the territorial waters of a state, where national legislation does not apply. Most commercial offshore diving is in the Exclusive Economic Zone of a state, and much of it is outside the territorial waters. Offshore diving beyond the EEZ does also occur, and is often for scientific purposes.
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It was developed by Novo Nordisk in 2012 and approved for use in the US in 2017. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold under the brand names Ozempic (injectable) and Rybelsus (pill) for diabetes, and under the brand name Wegovy for weight loss.
The distribution of medications has special drug safety and security considerations. Some drugs require cold chain management in their distribution.
